Gastric Cancer Therapeutics Market – Global Industry Insights, Trends and Opportunity Analysis, 2016–2024
Gastric cancer, also known as stomach cancer, is a type of cancer that develops within the inside layer of the stomach. Symptoms may include upper abdominal pain, yellowing of the skin, heartburn, sudden weight loss, blood in the stool, loss of appetite, and nausea, among others. This type of cancer may multiply to unaffected parts of the body mainly to the lungs, liver, the lining of the abdomen, lymph nodes, and bones. The key cause of gastric cancer is contagion by Helicobacter pylori. This accounts for around 60% of the gastric cancer cases. Some types of H. pylori comprise larger risks than the others. Some of the other causes include smoking and eating pickled vegetables. Around 1 in 10 cases of gastric cancer are inherited and 1% to 3% of the cases are due to hereditary syndromes such as hereditary gastric cancer. Most cases of gastric cancers are gastric carcinomas.
Gastric cancer, also known as stomach cancer, is a type of cancer that develops within the inside layer of the stomach. Symptoms may include upper abdominal pain, yellowing of the skin, heartburn, sudden weight loss, blood in the stool, loss of appetite, and nausea, among others. This type of cancer may multiply to unaffected parts of the body mainly to the lungs, liver, the lining of the abdomen, lymph nodes, and bones. The key cause of gastric cancer is contagion by Helicobacter pylori. This accounts for around 60% of the gastric cancer cases. Some types of H. pylori comprise larger risks than the others. Some of the other causes include smoking and eating pickled vegetables. Around 1 in 10 cases of gastric cancer are inherited and 1% to 3% of the cases are due to hereditary syndromes such as hereditary gastric cancer. Most cases of gastric cancers are gastric carcinomas.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
REPORT DESCRIPTION<br />
<strong>Gastric</strong> <strong>Cancer</strong> <strong>Therapeutics</strong> <strong>Market</strong> : Overview<br />
<strong>Gastric</strong> cancer, also known as stomach cancer, is a type of cancer that develops within<br />
the inside layer of the stomach. Symptoms may include upper abdominal pain,<br />
yellowing of the skin, heartburn, sudden weight loss, blood in the stool, loss of<br />
appetite, <strong>and</strong> nausea, among others. This type of cancer may multiply to unaffected<br />
parts of the body mainly to the lungs, liver, the lining of the abdomen, lymph nodes,<br />
<strong>and</strong> bones. The key cause of gastric cancer is contagion by Helicobacter pylori. This<br />
accounts for around 60% of the gastric cancer cases. Some types of H. pylori comprise<br />
larger risks than the others. Some of the other causes include smoking <strong>and</strong> eating<br />
pickled vegetables. Around 1 in 10 cases of gastric cancer are inherited <strong>and</strong> 1% to 3% of<br />
the cases are due to hereditary syndromes such as hereditary gastric cancer. Most cases<br />
of gastric cancers are gastric carcinomas.<br />
According to World <strong>Cancer</strong> Research Fund International, 952,000 new cases of gastric<br />
cancer were diagnosed in 2012. <strong>Gastric</strong> cancer was the fifth-most common type of<br />
cancer in the world. This epidemic has forced researchers, doctors, <strong>and</strong> governments to<br />
adopt various therapeutic treatments related to gastric cancer. An increase in<br />
investment by the companies <strong>and</strong> regulations by the government encouraging research<br />
on the same has provided significant momentum to the growth of the gastric cancer<br />
therapeutics market. This trend is likely to persist throughout the forecast period, since<br />
the number of cases of gastric cancer around the globe is rising at an alarming rate.<br />
© Coherent market <strong>Insights</strong>. All Rights Reserved
Change language